Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
advisory, binding, Breast, category, Center, COBRA, DENALI, DPF, franchise, gynecologic, Head, Lackner, longevity, lump, malignancy, MAMMOTH, Mark, mechanism, outlining, pembrolizumab, platinum, PSOC, resistant, salary, signal, TETON, TNBC, Translational, Triple
Removed:
classification, Connective, effectuated, heterobifunctional, IND, shareholder, Society, SVB, tyrosine, Ukraine, women
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view